$CB

GREENBERG EVAN G sold (to issuer) 11,253 shares of CB

GREENBERG EVAN G (Chairman & CEO) sold (to issuer) 11,253 shares of Chubb Ltd (CB) on 2026-05-21.

Original reporting
SEC EDGAR · GREENBERG EVAN G
Published May 26, 2026, 8:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 26, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CB
Neutral
medium confidence
Mentioned
$CB
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBNeutralLow
01

Why it matters

Because the filing lacks disclosed price/value and provides no operational or financial catalyst, it is unlikely to change valuation expectations; it mainly updates insider activity monitoring.

02

Market read

Use as a signal for insider-activity surveillance, not as a standalone fundamental catalyst.

03

What to watch

The code is D (sale to issuer), which can reflect buyback participation or other structured liquidity events rather than a bearish view.

Relevance 6/10Timing: Immediate (today’s Form 4 filing), but limited incremental information for trading.

Background

The article is an SEC Form 4 insider transaction: Chubb’s Chairman/CEO sold 11,253 shares to the issuer (code D) and reported holdings of 535,346 shares after the trade.

Company-level read

Ticker impact

$CBNeutralMedium confidence
Context

Chubb (CB) disclosed an insider sale to the issuer by Chairman/CEO Greenberg for 11,253 shares on 2026-05-21.

Expected impact

Likely minimal near-term impact; any move would be noise unless follow-on filings show sustained selling.

Evidence & confidence

Form 4 insider sales are often administrative (e.g., tax/plan-related), and the article provides no transaction price or value to gauge materiality.

Market effects

Minimal—single-company insider Form 4 with no disclosed economic terms usually doesn’t reset sector expectations.

None indicated; filing is company-specific.

None indicated; no cross-border deal/regulatory catalyst mentioned.

Counterpoint

Even without disclosed price/value, absence of a 10b5-1 plan can prompt traders to watch for additional insider selling in subsequent filings.

Key entities

  • Chubb Ltd

    Subject of the Form 4 insider transaction disclosure (CB).

  • Evan G. Greenberg

    Chairman & CEO who reported the sale to the issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBMed

Fed hikes again - an AI-Picked insurer is still cashing in

The Federal Reserve raised rates, impacting markets. Investing.com's AI models show varied portfolio performance. Chubb (CB) is benefiting from higher rates, with a 1.13% monthly gain, due to its Treasury investments. CB's earnings beat estimates, and it trades at a low forward P/E. The Fed's decision is affecting sectors differently.

$CBMed

Is Wall Street Bullish or Bearish on Chubb Limited Stock?

Chubb Limited (CB), a global insurer, has seen its stock rise 26% over the past year, outpacing the S&P 500. In 2026, it gained 10.2%, underperforming the index. CB offers a 1.20% dividend yield and has increased payouts for 18 years. Analysts expect 10.7% EPS growth this year. The consensus rating is 'Moderate Buy' with a mean price target of $369.36, suggesting 6.1% upside.

$CBMed

What Chubb (CB)'s Earnings Beat and Completed Buyback Mean For Shareholders

Chubb Limited (CB) reported Q2 2026 earnings above analyst estimates, citing higher underwriting and investment income and 3.6% net premium written growth across Property & Casualty and Life. The company also completed a US$4.45 billion multi-year buyback totaling 14,811,112 shares. Chubb Tempest Re named James Wixtead Executive Chairman and Michael O’Donnell President.

$BAXMed

This week in insurance: Catastrophe losses ease, Allianz buys HSBC Life Singapore, Chubb launches shopping cover

A weekly insurance roundup said Asia’s insured natural-catastrophe losses in H1 2026 were under $2.0b, the lowest six-month total since 2017, citing Gallagher Re. It also covered rising transaction-risk claims and new products. Deal news included Allianz buying HSBC Life Singapore for S$2.7b, and Sompo International agreeing to buy Fator Seguradora in Brazil.